Nektar Therapeutics (NKTR) — 424B5 Filings
All 424B5 filings from Nektar Therapeutics. Browse 1 424B5 reports with AI-powered summaries and risk analysis.
424B5 Filings (1)
-
Nektar Therapeutics Files Prospectus for Stock Offering
— Apr 23, 2026 Risk: medium
Nektar Therapeutics filed a 424B5 prospectus on April 23, 2026, detailing the terms of a public offering. The filing indicates the company is offering shares of
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX